- Home
- PLTK vs NVCR Comparison
PLTK vs NVCR Comparison
Compare PLTK & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLTK | NVCR |
|---|---|---|
| Founded | 2010 | 2000 |
| Country | Israel | Switzerland |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | PLTK | NVCR |
|---|---|---|
| Price | $3.61 | $10.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $6.61 | ★ $26.42 |
| AVG Volume (30 Days) | ★ 1.4M | 1.4M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | ★ 10.70% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $2,726,900,000.00 | $642,269,000.00 |
| Revenue This Year | $9.52 | $10.64 |
| Revenue Next Year | $2.58 | $5.37 |
| P/E Ratio | $16.18 | ★ N/A |
| Revenue Growth | 7.49 | ★ 11.17 |
| 52 Week Low | $3.31 | $9.82 |
| 52 Week High | $7.55 | $22.95 |
Technical Indicators
Market Signals| Indicator | PLTK | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 46.23 | 30.59 |
| Support Level | $3.35 | $9.82 |
| Resistance Level | $3.76 | $12.91 |
| Average True Range (ATR) | 0.16 | 0.62 |
| MACD | 0.02 | -0.33 |
| Stochastic Oscillator | 57.83 | 13.91 |
Price Performance
Historical ComparisonAbout PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.